Raising awareness amongst appropriate HHS officials of the company's challenges as it attempts to move forward with its drug.
2025 · 4th Quarter (Oct 1 - Dec 31)
CBA PHARMA INC.
Filed by TENAGRITY SOLUTIONS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- TENAGRITY SOLUTIONS, LLC
- Client
- CBA PHARMA INC.
- Filing UUID
- 0b1d9cef-4813-4ce6-af18-4b1e753b6c62
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Raising awareness amongst DOJ officials of the company's challenges as it attempts to move forward with its drug.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.